Search
for
Sort by
Research 30 of 122
- Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome
- A Clinical Approach to Severe Insulin Resistance
- Obesity and the Polycystic Ovary Syndrome
- Unravelling the link between insulin resistance and androgen excess
- Polycystic Ovary Syndrome
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Insulin Resistance and Skin Diseases
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- What do users in a polycystic ovary syndrome (PCOS) forum think about the treatments they tried: Analysing treatment sentiment using machine learning
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Adult polycystic ovary syndrome begins in childhood
- Syndromes of Severe Insulin Resistance (SSIRs)
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- Comparison of mathematical indices of insulin resistance for clinical application in the four phenotypes of polycystic ovarian syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism